Cargando…
A novel tumor mutational burden-based risk model predicts prognosis and correlates with immune infiltration in ovarian cancer
Tumor mutational burden (TMB) has been reported to determine the response to immunotherapy, thus affecting the patient’s prognosis in many cancers. However, it is unclear whether TMB or TMB-related signature could be used as prognostic indicators for ovarian cancer (OC), as its potential association...
Autores principales: | Wang, Haoyu, Liu, Jingchun, Yang, Jiang, Wang, Zhi, Zhang, Zihui, Peng, Jiaxin, Wang, Ying, Hong, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393426/ https://www.ncbi.nlm.nih.gov/pubmed/36003381 http://dx.doi.org/10.3389/fimmu.2022.943389 |
Ejemplares similares
-
A degradome-based prognostic signature that correlates with immune infiltration and tumor mutation burden in breast cancer
por: Luo, Yulou, et al.
Publicado: (2023) -
Significance of tumor mutation burden combined with immune infiltrates in the progression and prognosis of ovarian cancer
por: Bi, Fangfang, et al.
Publicado: (2020) -
Correlation of tumor mutational burden with prognosis and immune infiltration in lung adenocarcinoma
por: Li, Lin, et al.
Publicado: (2023) -
Burden of ovarian cancer in China from 1990 to 2030: A systematic analysis and comparison with the global level
por: Wang, Ying, et al.
Publicado: (2023) -
Significance of Tumor Mutation Burden in Immune Infiltration and Prognosis in Cutaneous Melanoma
por: Kang, Kai, et al.
Publicado: (2020)